Stocks
Sarepta Therapeutics (SRPT) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -45.2% | -63.8% | -36.5% | 16.7% | -29.5% | 5.72% | ||
| Changes by years, y/y, % | +39pp | -19pp | +27pp | +53pp | -46pp | -18.9% | |||
Sarepta Therapeutics. EBITDA margin, %
Sarepta Therapeutics. EBITDA margin, changes, pp
Sarepta Therapeutics (SRPT) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | -49.5% | 27.8% | -42.1% | -56.9% | 51.4% | 5.72% | |
| Changes by years, y/y, % | -63pp | +20pp | -53pp | -85pp | +101pp | |||
| Changes by quarters, q/q, % | -78pp | +77pp | -70pp | -15pp | +108pp | |||
